Anadys Pharmaceuticals, Inc. (ANDS) Reports Third Quarter 2011 Financial Results and Highlights
11/7/2011 3:22:13 PM
More...
|
Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. (ANDS)
10/20/2011 11:43:54 AM
More...
|
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals, Inc. (ANDS) in Connection with the Sale of the Company to Roche Holding AG (RHHBF.PK)
10/17/2011 1:49:30 PM
More...
|
Roche (RHHBY) Buys Anadys Pharmaceuticals, Inc. (ANDS) for $230 Million to Boost Hepatitis Ops
10/17/2011 7:30:46 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study
10/13/2011 6:47:12 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) to Present at Two Upcoming Investor Conferences
9/16/2011 6:03:47 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS)' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch
9/8/2011 5:41:54 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference
9/7/2011 5:36:11 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) to Present at Two Upcoming Investor Conferences
9/2/2011 5:56:06 AM
More...
|
Anadys Pharmaceuticals, Inc. (ANDS) Appoints Brian S. Posner to Its Board of Directors
8/23/2011 5:46:48 AM
More...
|
|